Open AccessUndisclosed Antiretroviral Drug Use in a Multinational Clinical Trial (HIV Prevention Trials Network 052)
Author(s) -
Jessica M. Fogel,
Lei Wang,
Teresa L. Parsons,
San San Ou,
Estelle PiwowarManning,
Ying Chen,
Victor Mudhune,
Mina C. Hosseinipour,
Johnstone Kumwenda,
James Hakim,
Suwat Chariyalertsak,
Ravindre Panchia,
Ian Sanne,
Nagalingeswaran Kumarasamy,
Beatriz Grinsztejn,
Joseph Makhema,
José Henrique Pilotto,
Breno Santos,
Kenneth H. Mayer,
Marybeth McCauley,
Theresa Gamble,
Namandjé N. Bumpus,
Craig W. Hendrix,
Myron S. Cohen,
Susan H. Eshleman
Publication year - 2013
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - Uncategorized
DOI - 10.17615/5e55-6021
Subject(s) - antiretroviral drug , human immunodeficiency virus (hiv) , clinical trial , drug trial , multinational corporation , drug , medicine , antiretroviral therapy , virology , pharmacology , business , viral load , finance